Centers for Disease Control and Prevention - ERA

Description

The purpose of this FOA is to conduct research to assess the impact of policies and administrative practices on the inappropriate prescribing or abuse of prescription opioid analgesics. This funding will support projects that: (1) evaluate the impact of current legislation that requires state oversight of pain management clinics or sets out registration, licensure, or ownership requirements for such clinics, or (2) evaluate the impact of formulary management and benefit design strategies used by public or private insurers and pharmacy benefit managers (e.g., quantity limits, step therapies, preferred drug lists, prior authorization, tiered formularies, and drug utilization review programs) that are applicable to all beneficiaries, not just those identified as abusing drugs or engaged in fraudulent activity.

Who can apply

• State governments
• County governments
• City or township governments
• Special district governments
• Independent school districts
• Public and State controlled institutions of higher education
• Native American tribal governments (Federally recognized)
• Public housing authorities / Indian housing authorities
• Native American tribal organizations (other than Federally recognized)
• Nonprofits with 501(c)(3) status (other than higher education)
• Private institutions of higher education
• For-profit organizations other than small businesses
• Small businesses
• Others

Contact

CDC <br/>Procurement and Grants Office (PGO) <br/>Technical Information Management Section (TIMS) <br/>Phone: 770-488-2700
pgotim@cdc.gov